Global Regulatory Scrutiny Will Undermine MLM And Supplement Models

Published
24 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$9.00
6.8% overvalued intrinsic discount
14 Aug
US$9.61
Loading
1Y
14.4%
7D
7.9%

Author's Valuation

US$9.0

6.8% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on19 Mar 25
Fair value Increased 2.39%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 1.42%

AnalystConsensusTarget has increased revenue growth from 1.7% to 3.1%, decreased profit margin from 5.9% to 3.9% and increased future PE multiple from 4.2x to 5.9x.